メインコンテンツにスキップ
検索

後期臨床

登録

最新のリソース

注目コンテンツ

Upcoming late clinical webinars

Latest late clinical blogs

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
対面セミナー・イベント

Certainty Korea 2025​

2025年9月18日 – Conrad Seoul
対面セミナー・イベント

Certainty China 2025​

2025年9月23日 – Crowne Plaza Shanghai Jinxiu

All late clinical resources

Accelerating Oncology Drug FDA Submission with Project Management Services

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation – PK/PD, Oncology/Hematology, Case Study

Quantitative Systems Pharmacology-Based Digital Twins Approach for Clinical Development in Rare Diseases

Modeling and Simulation - QSP, Webinar

Pirana Tips and Tricks – Report Object Generation in Pirana

サターラの製品、ウェビナー

The Reference-scaled Average Bioequivalence (RSABE) Approach

Certara Products, Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

How Model-informed drug development rescue projects from a risky situation​

Certara Services, Clinical Pharmacology, Homepage Latest, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Case Study

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

Faster Mapping from Source Data to Target SDTM

Certara Products - Pinnacle 21, Webinar

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Pharmacometrics, Blog

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Cardiovascular, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Transform Your PK/PD Workflow with AI and the Cloud

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software